|Articles|January 1, 1996

January 1996
Volume 2
Issue 1

Who Keeps the Gender Gate: Ethical and Policy Implications of OB-GYNs as Primary Caregivers

Author(s)Glenn McGee, PhD, Monica Arruda

Download PDF: Who Keeps the Gender Gate: Ethical and Policy Implications of OB-GYNs as Primary Caregivers

Articles in this issue

over 30 years ago

Article

Impact of Insurance Type on Receipt of Medical Care by HIV-Infected Men

over 30 years ago

Article

Aspirin After Myocardial Infarction: Patient Experience in a Managed Care Setting

over 30 years ago

Article

The Palliation of Cancer Patients -- Balancing Quality of Life, Cost, and Therapy

over 30 years ago

Article

Modeling the Cost-Effectiveness of Oral Therapy for Nail Fungus

over 30 years ago

Article

The Use of Patient-Perceived Outcome Data in Today's Competitive Managed Care Environment: Suggestions for Providers and Managed Care Organizations

over 30 years ago

Article

Managed Care and HIV Disease

over 30 years ago

Article

Enhancing Skills in Clinical Resource Management: A Managed Care Approach

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

June 4th 2026

Who Keeps the Gender Gate: Ethical and Policy Implications of OB-GYNs as Primary Caregivers

Articles in this issue

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Trending on AJMC

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD

Oral Orforglipron Added to Basal Insulin Cuts HbA1c in Type 2 Diabetes

GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis